Argenica Therapeutics
Nedlands
About Argenica Therapeutics
Argenica Therapeutics is a developing novel neuroprotective therapeutics to reduce brain damage after stroke.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $1.5M
- Funding stage: IPO
- Last round: Grant (Jun 2025)
- Ticker: asx:AGN
- Website: argenica.com.au
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/argenica-therapeutics-124360 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.